C
27.48
-0.05 (-0.18%)
| Penutupan Terdahulu | 27.53 |
| Buka | 27.46 |
| Jumlah Dagangan | 207,609 |
| Purata Dagangan (3B) | 383,846 |
| Modal Pasaran | 769,640,576 |
| Harga / Pendapatan (P/E TTM) | 130.86 |
| Harga / Jualan (P/S) | 2.50 |
| Harga / Buku (P/B) | 1.75 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | 1.95% |
| Margin Operasi (TTM) | 5.92% |
| EPS Cair (TTM) | 0.210 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 39.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.06% |
| Nisbah Semasa (MRQ) | 7.78 |
| Aliran Tunai Operasi (OCF TTM) | 59.09 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 30.83 M |
| Pulangan Atas Aset (ROA TTM) | -0.14% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | Castle Biosciences, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.38% |
| % Dimiliki oleh Institusi | 94.51% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 44.00 (Scotiabank, 60.12%) | Beli |
| Median | 40.00 (45.56%) | |
| Rendah | 36.00 (Keybanc, 31.00%) | Beli |
| Purata | 40.29 (46.62%) | |
| Jumlah | 7 Beli | |
| Harga Purata @ Panggilan | 31.74 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Stephens & Co. | 02 Jan 2025 | 41.00 (49.20%) | Beli | 28.04 |
| Scotiabank | 06 Nov 2024 | 44.00 (60.12%) | Beli | 32.66 |
| Baird | 05 Nov 2024 | 39.00 (41.92%) | Beli | 31.15 |
| Keybanc | 05 Nov 2024 | 36.00 (31.00%) | Beli | 31.15 |
| Lake Street | 05 Nov 2024 | 40.00 (45.56%) | Beli | 31.15 |
| Canaccord Genuity | 29 Oct 2024 | 42.00 (52.84%) | Beli | 33.78 |
| BTIG | 14 Oct 2024 | 40.00 (45.56%) | Beli | 34.26 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |